Ironwood Pharmaceuticals, Inc. - (IRWD): Price and Financial Metrics

IRWD POWR Grades

• IRWD scores best on the Quality dimension, with a Quality rank ahead of 92.13% of US stocks.
• The strongest trend for IRWD is in Value, which has been heading down over the past 177 days.
• IRWD ranks lowest in Sentiment; there it ranks in the 12th percentile.

IRWD Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for IRWD is -1.34 -- better than merely 5.1% of US stocks.
• Of note is the ratio of IRONWOOD PHARMACEUTICALS INC's sales and general administrative expense to its total operating expenses; just 3.59% of US stocks have a lower such ratio.
• Over the past twelve months, IRWD has reported earnings growth of -470.19%, putting it ahead of merely 3.16% of US stocks in our set.
• If you're looking for stocks that are quantitatively similar to IRONWOOD PHARMACEUTICALS INC, a group of peers worth examining would be KOS, CHK, JRVR, EQT, and SM.
• Visit IRWD's SEC page to see the company's official filings. To visit the company's web site, go to www.ironwoodpharma.com.

IRWD Valuation Summary

• In comparison to the median Healthcare stock, IRWD's price/earnings ratio is 106.58% lower, now standing at -1.6.
• Over the past 167 months, IRWD's EV/EBIT ratio has gone up 11.8.

Below are key valuation metrics over time for IRWD.

IRWD Growth Metrics

Its 4 year cash and equivalents growth rate is now at 72.77%.
• The 5 year price growth rate now stands at -33.93%.
• Its 3 year cash and equivalents growth rate is now at 394.3%.

Over the past 34 months, IRWD's revenue has gone down $29,030,000.

The table below shows IRWD's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	410.596	273.763	175.065
2022-09-30	420.527	259.149	167.572
2022-06-30	415.637	265.122	173.1
2022-03-31	422.437	252.325	527.323
2021-12-31	413.753	261.895	528.448
2021-09-30	413.303	248.84	530.278

IRWD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• IRWD has a Quality Grade of B, ranking ahead of 94.53% of graded US stocks.
• IRWD's asset turnover comes in at 0.622 -- ranking 50th of 682 Pharmaceutical Products stocks.
• LGND, COLL, and OMER are the stocks whose asset turnover ratios are most correlated with IRWD.

The table below shows IRWD's key quality metrics over time.